Skip to the page

Data / Medical devices / Sweden / Fujirebio Diagnostics AB

Fujirebio Diagnostics AB: FDA-registered device maker in Molndal Vastra Gotaland, Sweden, 1 510(k) clearance

Fujirebio Diagnostics AB is registered with the FDA (registration 3027273565) in Molndal Vastra Gotaland, Sweden. It lists 1 device type. The FDA files 1 510(k) clearance under its listings, the newest dated October 5, 2010. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3027273565
Address
Gemenskapens gata 7, Molndal Vastra Gotaland, Sweden, SE-431 53
Owner or operator
Fujirebio Diagnostics, Inc. (10022860)
Roles
Manufacturer
First device listed
December 2, 2010
Registered through
2026
Brand names listed
AMH Controls, Fujirebio Diagnostics Tumor Marker Control

Devices it lists

DeviceProduct codeClassRoleSource
Multi-Analyte Controls, All Kinds (Assayed)JJY1Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
October 5, 2010K101809FUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROL MODEL 108-20JJYSubstantially EquivalentFujirebio Diagnostics,Inc.accessdata.fda.gov

Compare with other makers

Updated October 5, 2010. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.